Our clinical studies of cancer patients undergoing chemotherapy found a correlation between pro-inflammatory signaling via TNFa, reduced plasma BDNF, and persistent cognitive impairments [44, 45], pointing to a neuro-modulatory role of inflammation and BDNF. The gene discussed is TNF; the disease is Cognitive impairment.